ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

Issues and current Developments in Biophramacrutical Oral drug Delivery system.

Authors

Mr. Pradip Sanjay Pawar , Mr. Hemant Sunil Mali

Keywords

Abstract

Oral drug delivery remains the most favored route of administration due to its noninvasive nature, high patient compliance, ease of handling, and lack of requirement for specific sterile conditions. Nevertheless, numerous drugs delivered orally encounter various physical, biological, and biochemical obstacles that diminish their therapeutic effectiveness prior to absorption into systemic circulation. The application of nanocarriers in oral drug delivery serves to mitigate these challenges and is regarded as a viable alternative to address the limitations associated with traditional oral drug delivery methods. This chapter provides a summary of recent advancements in the use of nanocarriers for oral drug delivery aimed at treating a range of diseases. Additionally, it discusses how innovative nanocarrier design technologies enhance therapeutic efficacy by overcoming the aforementioned barriers. Although several nanocarrier-based drug delivery technologies have emerged in recent years and demonstrate promising outcomes, they remain distant from widespread clinical application

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJRTI — journal style
"Issues and current Developments in Biophramacrutical Oral drug Delivery system.", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.10, Issue 1, page no.a235-a251, January-2025, Available :https://ijrti.org/papers/IJRTI2501033.pdf
APA — 7th edition
Pawar, P. S., & Mali, H. S. (2025). Issues and current Developments in Biophramacrutical Oral drug Delivery system. International Journal for Research Trends and Innovation, 10(1), a235-a251. https://ijrti.org/viewpaperforall.php?paper=IJRTI2501033
MLA — 9th edition
Pawar, Pradip Sanjay, and Hemant Sunil Mali. "Issues and current Developments in Biophramacrutical Oral drug Delivery system." International Journal for Research Trends and Innovation, vol. 10, no. 1, 2025, pp. a235-a251, https://ijrti.org/viewpaperforall.php?paper=IJRTI2501033.
Chicago — 17th, bibliography
Pawar, Pradip Sanjay, and Hemant Sunil Mali. "Issues and current Developments in Biophramacrutical Oral drug Delivery system." International Journal for Research Trends and Innovation 10, no. 1 (2025): a235-a251. https://ijrti.org/viewpaperforall.php?paper=IJRTI2501033.
Harvard — author–date
Pawar, P.S. and Mali, H.S. (2025) 'Issues and current Developments in Biophramacrutical Oral drug Delivery system', International Journal for Research Trends and Innovation, 10(1), pp. a235-a251. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2501033
IEEE — numbered reference
P. S. Pawar and H. S. Mali, "Issues and current Developments in Biophramacrutical Oral drug Delivery system," IJRTI, vol. 10, no. 1, pp. a235-a251, Jan. 2025.
Vancouver — biomedical
Pawar PS, Mali HS. Issues and current Developments in Biophramacrutical Oral drug Delivery system. IJRTI. 2025 Jan;10(1):a235-a251.
AMA — 11th edition
Pawar PS, Mali HS. Issues and current Developments in Biophramacrutical Oral drug Delivery system. IJRTI. 2025;10(1):a235-a251. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2501033
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2501033, author = {Pradip Sanjay Pawar and Hemant Sunil Mali}, title = {Issues and current Developments in Biophramacrutical Oral drug Delivery system.}, journal = {International Journal for Research Trends and Innovation}, volume = {10}, number = {1}, pages = {a235-a251}, year = {2025}, month = {January}, issn = {2456-3315}, url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2501033} }
RIS — EndNote, RefWorks
TY - JOUR AU - Pawar, Pradip Sanjay AU - Mali, Hemant Sunil TI - Issues and current Developments in Biophramacrutical Oral drug Delivery system. T2 - International Journal for Research Trends and Innovation JA - IJRTI VL - 10 IS - 1 PY - 2025 SN - 2456-3315 UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2501033 SP - a235-a251 ER -

Issue

Volume 10 Issue 1, January-2025
Pages : a235-a251

Other Publication Details

Paper Reg. ID IJRTI_200292
Published Paper ID IJRTI2501033
Downloads 205,616
Research Area Pharmacy
Country Shindkheda, Maharashtra, India
Published January 2025

About Publisher

International Journal for Research Trends and Innovation Published by IJRTI (JW Publication)
2456-3315 ISSN
10.57 Impact Factor
2016 ESTD Year
Open Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.

Licence

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹599
Publish in a UGC CARE Approved Journal | Low Cost ₹599 Indian Author | 🌐 $45 USD International
CrossRef/DataCite DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →